Nuclear envelope barrier leak induced by dexamethasone

Journal of Cellular Physiology

Volumn 206, Issue 2, 2006, Pages 428-434

  Kastrup, Lilian ^a   Oberleithner, Hans ^a   Ludwig, Yvonne ^a   Schafer, Claudia ^a   Shahin, Victor ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUCOCORTICOID;

ANIMAL CELL; ARTICLE; CELL NUCLEUS MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; MACROMOLECULE; MEMBRANE PERMEABILITY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; XENOPUS LAEVIS;

ANIMALS; DEXAMETHASONE; DEXTRANS; FEMALE; MICROSCOPY, ATOMIC FORCE; NUCLEAR ENVELOPE; NUCLEAR PORE; OOCYTES; PERMEABILITY; XENOPUS;

ANIMALIA; XENOPUS LAEVIS;

EID: 30344441142     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20479     Document Type: Article

References (51)

1. Agata N, Nogi H, Milhollen M, Kharbanda S, Kufe D. 2004. 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl)propionic acid, a small molecule isocoumarin, potentiates dexamethasone-induced apoptosis of human multiple myeloma cells. Cancer Res 64:8512-8516.
2. Akey CW. 1995. Structural plasticity of the nuclear pore complex. J Mol Biol 248:273-293.
3. Akey CW, Radermacher M. 1993. Architecture of the Xenopus nuclear pore complex revealed by three-dimensional cryo-electron microscopy. J Cell Biol 122:1-19.
4. Allen TD, Cronshaw JM, Bagley S, Kiseleva E, Goldberg MW. 2000. The nuclear pore complex: Mediator of translocation between nucleus and cytoplasm. J Cell Sci 113(Pt 10):1651-1659.
5. Anderson WF. 1998. Human gene therapy. Nature 392:25-30.
6. Belgareh N. Doye V. 1997. Dynamics of nuclear pore distribution in nucleoporin mutant yeast cells. J Cell Biol 136:747-759.
7. Bernasconi AG, Rebuffat AG, Lovati E, Frey BM, Frey FJ, Galli I. 1997. Cortisol increases transfection efficiency of cells. FEBS Lett 419:103-106.
8. Braun S, Jenny C, Thioudellet C, Perraud F, Claudepierre MC, Langle-Rouault F, Ali-Hadji D, Schughart K, Pavirani A. 1999. In vitro and in vivo effects of glucocorticoids on gene transfer to skeletal muscle. FEBS Lett 454:277-282.
9. Bucci M, Wente SR. 1997. In vivo dynamics of nuclear pore complexes in yeast. J Cell Biol 136:1185-1199.
10. Chan CK, Jans DA. 2002. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol Cell Biol 80:119-130.
11. Chan CK, Senden T, Jans DA. 2000. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines. Gene Ther 7:1690-1697.
12. Chrysis D, Zaman F, Chagin AS, Takigawa M, Savendahl L. 2005. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3A-kinase signaling pathway. Endocrinology 146:1391-1397.
13. Colin M, Moritz S, Fontanges P, Kornprobst M, Delouis C, Keller M, Miller AD, Capeau J, Coutelle C, Brahimi-Horn MC. 2001. The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties. Gene Ther 8:1643-1653.
14. Danker T, Schillers H, Storck J, Shahin V, Kromer B, Wilhelmi M, Oberleithner H. 1999. Nuclear hourglass technique: novel approach detects electrically open pores in Xenopus laevis oocyte. Proc Natl Acad Sci USA 96:13531-13535.
15. Danker T, Shahin V, Schlune A, Schafer C, Oberleithner H. 2001. Electrophoretic plugging of nuclear pores by using the nuclear hourglass technique. J Membr Biol 184:91-99.
16. Escriou V, Carriere M, Bussone F, Wils P, Scherman D. 2001. Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer. J Gene Med 3:179-187.
17. Fahrenkrog B, Stoffler D, Aebi U. 2001. Nuclear pore complex architecture and functional dynamics. Curr Top Microbiol Immunol 259:95-117.
18. Feldherr C, Akin D, Littlewood T, Stewart M. 2002. The molecular mechanism of translocation through the nuclear pore complex is highly conserved. J Cell Sci 115:2997-3005.
19. Goldberg MW, Rutherford SA, Hughes M, Cotter LA, Bagley S, Kiseleva E, Allen TD, Clarke PR. 2000. Ran alters nuclear pore complex conformation. J Mol Biol 300:519-529.
20. Gorlich D, Mattaj IW. 1996. Nucleoplasmic transport. Science 271:1513-1518.
21. Gruneich JA, Price A, Zhu J, Diamond SL. 2004. Cationic corticosteroid for nonviral gene delivery. Gene Ther 11:668-674.
22. Hebert E. 2003. Improvement of exogenous DNA nuclear importation by nuclear localization signal-bearing vectors: A promising way for non-viral gene therapy? Biol Cell 95:59-68.
23. Jaggi RD, Franco-Obregon A, Muhlhausser P, Thomas F, Kutay U, Ensslin K. 2003. Modulation of nuclear pore topology by transport modifiers. Biophys J 84:665-670.
24. Johnson-Saliba M, Jans DA. 2001. Gene therapy: Optimising DNA delivery to the nucleus. Curr Drug Targets 2:371-399.
25. Lechardeur D, Lukacs GL. 2002. Intracellular barriers to non-viral gene transfer. Curr Gene Ther 2:183-194.
26. Lenart P, Rabut G, Daigle N, Hand AR, Terasaki M, Ellenberg J. 2003. Nuclear envelope breakdown in starfish oocytes proceeds by partial NPC disassembly followed by a rapidly spreading fenestration of nuclear membranes. J Cell Biol 160:1055-1068.
27. Loewenstein WR. 1965. Permeability of a nuclear membrane: Changes during normal development and changes induced by growth hormone. Science 150:909-910.
28. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ. 1998. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1:69-73.
29. Mazzanti M, Bustamante JO, Oberleithner H. 2001. Electrical dimension of the nuclear envelope. Physiol Rev 81:1-19.
30. Meaney MJ, O'Donnell D, Rowe W, Tannenbaum B, Steverman A, Walker M, Nair NP, Lupien S. 1995. Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol 30:229-251.
31. Miller DB, O'Callaghan JP. 2003. Effects of aging and stress on hippocampal structure and function. Metabolism 52:17-21.
32. Mountain A. 2000. Gene therapy: The first decade. Trends Biotechnol 18:119-128.
33. Newmeyer DD, Forbes DJ. 1988. Nuclear import can be separated into distinct steps in vitro: nuclear pore binding and translocation. Cell 52:641-653.
34. Oberleithner H, Brinckmann E, Schwab A, Krohne G. 1994. Imaging nuclear pores of aldosterone sensitive kidney cells by atomic force microscopy. Proc Natl Acad Sci USA 91:9784-9788.
35. 2 imaged with atomic force microscopy. Pflugers Arch 439:251-255.
36. Pante N, Aebi U. 1993. The nuclear pore complex. J Cell Biol 122:977-984.
37. 2+ stores. Science 273:1875-1877.
38. Rakowska A, Danker T, Schneider SW, Oberleithner H. 1998. ATP-induced shape change of nuclear pores visualized with the atomic force microscope. J Membr Biol 163:129-136.
39. Rebuffat A, Bernasconi A, Ceppi M, Wehrli H, Verca SB, Ibrahim M, Frey BM, Frey FJ, Rusconi S. 2001. Selective enhancement of gene transfer by steroid-mediated gene delivery. Nat Biotechnol 19:1155-1161.
40. Rebuffat AG, Nawrocki AR, Nielsen PE, Bernasconi AG, Bernal-Mendez E, Frey BM, Frey FJ. 2002. Gene delivery by a steroid-peptide nucleic acid conjugate. FASEB J 16:1426-1428.
41. Ribbeck K, Gorlich D. 2002. The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. Embo J 21:2664-2671.
42. Salman H, Zbaida D, Rabin Y, Chatenay D, Elbaum M. 2001. Kinetics and mechanism of DNA uptake into the cell nucleus. Proc Natl Acad Sci USA 98:7247-7252.
43. Schafer C, Shahin V, Albermann L, Hug MJ, Reinhardt J, Schillers H, Schneider SW, Oberleithner H. 2002. Aldosterone signaling pathway across the nuclear envelope. Proc Natl Acad Sci USA 99:7154-7159.
44. 2+- and ATP-sensitive peripheral channels in nuclear pore complexes. FASEB J 15:1895-1901.
45. Shahin V, Albermann L, Schillers H, Kastrup L, Schafer C, Ludwig Y, Stock C, Oberleithner H. 2004. Steroids dilate nuclear pores imaged with atomic force microscopy. J Cell Physiol 202:591-601.
46. Shahin V, Ludwig Y, Schafer C, Nikova D, Oberleithner H. 2005. Glucocorticoids remodel nuclear envelope structure and permeability. J Cell Sci (in press) 2005.
47. Stoffler D, Goldie KN, Feja B, Aebi U. 1999. Calcium-mediated structural changes of native nuclear pore complexes monitored by time-lapse atomic force microscopy. J Mol Biol 287:741-752.
48. Verma IM, Somia N. 1997. Gene therapy-promises, problems, and prospects. Nature 389:239-242.
49. Wang H, Clapham DE. 1999. Conformational changes of the in situ nuclear pore complex. Biophys J 77:241-247.
50. Wiethoff CM, Middaugh CR. 2003. Barriers to nonviral gene delivery. J Pharm Sci 92:203-217.
51. Yau JL, Noble J, Kenyon CJ, Hibberd C, Kotelevtsev Y, Mullins JJ, Seckl JR. 2001. Lack of tissue glucocorticoid reactivation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci USA 98:4716-4721.